Skip to content
10-Q

Quarterly Report

AtriCure, Inc. ATRC

0001323885-25-000043

← back to feed
Filed
Apr 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 28, 2025 49.5M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $61.87M
Long Term Debt Q1 2025 · Dec 31, 2024 $61.87M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $99.89M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $122.72M
Current Liabilities Q1 2025 · Mar 31, 2025 $61.22M
Current Liabilities Q1 2025 · Dec 31, 2024 $73.42M
Total Liabilities Q1 2025 · Mar 31, 2025 $137.01M
Total Liabilities Q1 2025 · Dec 31, 2024 $148.36M
Current Assets Q1 2025 · Mar 31, 2025 $251.48M
Current Assets Q1 2025 · Dec 31, 2024 $267.83M
Total Assets Q1 2025 · Mar 31, 2025 $591.63M
Total Assets Q1 2025 · Dec 31, 2024 $609.33M
Shares Diluted Q1 2025 · Mar 31, 2024 46.72M sh
Capex Q1 2025 · Mar 31, 2024 $2.77M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$21.02M
Stockholders Equity Q1 2025 · Mar 31, 2024 $456.31M
Stockholders Equity Q1 2025 · Dec 31, 2023 $466.17M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.28
Eps Basic Q1 2025 · Mar 31, 2024 −$0.28
Sga Expense Q1 2025 · Mar 31, 2024 $72.34M
Rd Expense Q1 2025 · Mar 31, 2024 $19.85M
Net Income Q1 2025 · Mar 31, 2024 −$13.27M
Operating Income Q1 2025 · Mar 31, 2024 −$10.92M
Gross Profit Q1 2025 · Mar 31, 2024 $81.27M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $27.58M
Revenue Q1 2025 · Mar 31, 2024 $108.85M